drugset / Trial / NCT02982798

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers

NCT02982798 ↗

Phase 1 Completed 40 enrolled Jeil Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open-label, single dose, crossover study to compare the pharmacokinetic characteristics of the co-administration of metformin SR and rosuvastatin and JLP-1310 in healthy male volunteers

Timeline

Start
2017-07-06
Primary completion
2017-08-30
Completion
2018-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject JLP-1310 Unknown — —
Subject Metformin Small molecule — —
Subject Rosuvastatin Small molecule — —